Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

The dual role of iNOS in cancer.

Vannini F, Kashfi K, Nath N.

Redox Biol. 2015 Dec;6:334-43. doi: 10.1016/j.redox.2015.08.009. Epub 2015 Aug 24. Review.

2.

Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.

Mesci A, Taeb S, Huang X, Jairath R, Sivaloganathan D, Liu SK.

World J Gastroenterol. 2014 Dec 14;20(46):17376-87. doi: 10.3748/wjg.v20.i46.17376.

3.

Chemoprevention of Colon Cancer by iNOS-Selective Inhibitors.

Janakiram NB, Rao CV.

For Immunopathol Dis Therap. 2012 Jan 1;3(2):155-167.

4.

Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Salvemini D, Kim SF, Mollace V.

Am J Physiol Regul Integr Comp Physiol. 2013 Apr 1;304(7):R473-87. doi: 10.1152/ajpregu.00355.2012. Epub 2013 Feb 6. Review.

5.

ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.

Oh S, Shin S, Janknecht R.

Biochim Biophys Acta. 2012 Aug;1826(1):1-12. doi: 10.1016/j.bbcan.2012.02.002. Epub 2012 Mar 8. Review.

6.

Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signaling.

Wollenick K, Hu J, Kristiansen G, Schraml P, Rehrauer H, Berchner-Pfannschmidt U, Fandrey J, Wenger RH, Stiehl DP.

Nucleic Acids Res. 2012 Mar;40(5):1928-43. doi: 10.1093/nar/gkr978. Epub 2011 Nov 10.

7.

Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.

Switzer CH, Glynn SA, Ridnour LA, Cheng RY, Vitek MP, Ambs S, Wink DA.

Trends Pharmacol Sci. 2011 Nov;32(11):644-51. doi: 10.1016/j.tips.2011.07.001. Epub 2011 Sep 4. Review.

8.

The role of nitric oxide in prostaglandin biology; update.

Kim SF.

Nitric Oxide. 2011 Oct 30;25(3):255-64. doi: 10.1016/j.niox.2011.07.002. Epub 2011 Jul 26. Review.

9.

PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma.

Keld R, Guo B, Downey P, Cummins R, Gulmann C, Ang YS, Sharrocks AD.

Br J Cancer. 2011 Jun 28;105(1):124-30. doi: 10.1038/bjc.2011.187. Epub 2011 Jun 14.

10.

Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases.

Mole DJ, O'Neill C, Hamilton P, Olabi B, Robinson V, Williams L, Diamond T, El-Tanani M, Campbell FC.

Br J Cancer. 2011 Mar 15;104(6):1007-12. doi: 10.1038/bjc.2011.33. Epub 2011 Feb 22.

11.
12.

Negative regulation of fibroblast growth factor 10 (FGF-10) by polyoma enhancer activator 3 (PEA3).

Chioni AM, Grose R.

Eur J Cell Biol. 2009 Jul;88(7):371-84. doi: 10.1016/j.ejcb.2009.01.004. Epub 2009 May 2.

14.

Ets transcription factors in intestinal morphogenesis, homeostasis and disease.

Jedlicka P, Gutierrez-Hartmann A.

Histol Histopathol. 2008 Nov;23(11):1417-24. Review.

15.

Hepatocyte growth factor regulates cyclooxygenase-2 expression via beta-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cells.

Lee YH, Suzuki YJ, Griffin AJ, Day RM.

Am J Physiol Lung Cell Mol Physiol. 2008 Apr;294(4):L778-86. doi: 10.1152/ajplung.00410.2007. Epub 2008 Feb 1.

16.

Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development.

Kasper LH, Fukuyama T, Biesen MA, Boussouar F, Tong C, de Pauw A, Murray PJ, van Deursen JM, Brindle PK.

Mol Cell Biol. 2006 Feb;26(3):789-809.

17.

Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis.

Nosho K, Yamamoto H, Adachi Y, Endo T, Hinoda Y, Imai K.

Br J Cancer. 2005 Apr 11;92(7):1193-200.

Items per page

Supplemental Content

Write to the Help Desk